Latest filing published 01 Jul 2010 for SCICLONE PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -60.1%Entry US$69.00 · Close at T+365 US$27.51
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Consultadoria & Servicos SDC Unipessoal LDA Chaumiere: trading record in brief
Filings by Consultadoria & Servicos SDC Unipessoal LDA Chaumiere span 2 companies, the busiest being Regenerx Biopharmaceuticals Inc and Sciclone Pharmaceuticals Inc. Between 10 December 2008 and 29 June 2010, the trades on record add up to 5 filings.
The open-market record is one-sided, with 4 purchases worth €2.4M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €565k.
The record was last updated on 1 July 2010 with a transaction in Sciclone Pharmaceuticals Inc. The last insider purchase was made public on 13 October 2009, 6,236 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Consultadoria & Servicos SDC Unipessoal LDA Chaumiere
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,289,052 sharesCommon StockSEC:0001181431-10-035630:0
- 312,500 shares@ US$0.40Common StockSEC:0001140361-09-014001:0Canonical exit: 31 Aug 2009 (T+90)
2 of 2 declarations